IL4, interleukin 4, 3565

N. diseases: 996; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Our results indicate that in females the TLR4 and IL4 genes show an epistatic effect on the risk of asthma. 16215326 2005
CUI: C0004096
Disease: Asthma
Asthma
0.600 AlteredExpression disease BEFREE The relative levels of miR-126 and IL-4 and the Th17 cell percentage were positively correlated with the severity of the asthma, while IFN-γ levels and the CD4<sup> 29809062 2018
CUI: C0004096
Disease: Asthma
Asthma
0.600 GeneticVariation disease BEFREE IL4-590*CT/TT and IL4-RP2*253183/183183 were found to predict the risk (2-fold) and severity (3 to 4-fold) of asthma and were associated with a lower FEV1 index. 25299150 2014
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE IL-4 is believed to perform important regulatory roles in asthma; however, the expression of the IL-4 receptor has not been investigated. 9819306 1998
CUI: C0004096
Disease: Asthma
Asthma
0.600 GeneticVariation disease BEFREE These findings provide support for the view that both chromosomes 5 and 11 may contain genes relevant to asthma and atopy, a possible candidate being the interleukin-4 (IL-4) gene cluster. 8616554 1996
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease RGD TLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organs. 21364926 2011
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Interestingly, these differences clustered in the genes highly associated with asthma (ORMDL family) and IgE regulation (RAD50, IL13, and IL4), but not in the T-regulatory genes (FOXP3, RUNX3). 23346934 2013
CUI: C0004096
Disease: Asthma
Asthma
0.600 Therapeutic disease RGD After the treatment, changes of EOS in peripheral blood of asthma rats were observed; enzyme linked immunosorbent assay (ELISA) was applied to test the contents of IgE, IL-4 and IFN-gamma in the lung tissue; real-time Q-PCR method was adopted to measure the expression level of transcription factor T-bet and GATA binding protein 3 (GATA-3) in the lung tissue. 24946644 2014
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE We propose that: (i) IL-4- and IL-13-stimulated SCCA gene expression is mediated via STAT-1 and STAT-6 activation, and (ii) by suppressing the production, and most likely by interfering with the signaling of these cytokines, UG inhibits SCCA gene expression associated with airway inflammation in asthma. 15677460 2005
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update. 27459348 2017
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Patients with asthma in whom the mucus score was high had raised Feno (P = .03) and IL-4 (P = .02) values. 30910637 2019
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. 11398072 2001
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE When both IL-4 and IL-5 were neutralized in this system, AHR was still induced, suggesting that influenza-induced cytokines such as IL-13, or mechanisms unrelated to cytokines, might be responsible for the development of AHR. 10975869 2000
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Our results suggest that when activated by IL-4 and IL-13, different subsets of lung fibroblasts may act as effector cells not only in the pathogenesis of asthma but also in lung remodeling processes. 9593769 1998
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. 8564096 1996
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Their Global Initiative for Asthma⁻based asthma severity, Childhood Asthma Control Test (C-ACT) scores, Pediatric Asthma Severity Scores, Pediatric Asthma Quality of Life Questionnaire scores, peak expiratory flow rates (PEFRs), medication use, the levels of immune biomarkers (immunoglobulin E (IgE), interferon γ, interleukin 4, and tumor necrosis factor α) at different visits, and the associated changes were evaluated. 30400588 2018
CUI: C0004096
Disease: Asthma
Asthma
0.600 GeneticVariation disease LHGDN These results indicate a possible involvement of SNPs in the IL4 gene in the development of asthma and the regulation of total serum IgE. 14610476 2003
CUI: C0004096
Disease: Asthma
Asthma
0.600 AlteredExpression disease BEFREE Compared with the asthma group, the IL-4R group had relatively regular tissue structure and light inflammation, declined maximal RL, numbers of total cells, EOS, neutrophils, and lymphocytes, contents of IgE, IL-4, IL-5 and IL-13, percentages of IFN-γ<sup>+</sup> CD4<sup>+</sup> and IFN-γ<sup>+</sup>/IL-4<sup>+</sup> in total T cells, mRNA expressions of IL-4, IL-5, IL-13, STAT6, pSTAT6, SOCS, iNOS and VCAM-1, and protein expressions of STAT6 and pSTAT6, but elevated IFN-γ content and percentage of IL-4<sup>+</sup> CD4<sup>+</sup> in total T cells. 28093225 2017
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE We also compared IL-4 production in peripheral blood mononuclear cells (PBMCs) from patients with AERD vs aspirin-tolerant asthma (ATA) upon exposure to aspirin. 27534531 2016
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE However, the relationships among IL-4, TRPC1 and mucus overproduction in bronchial epithelial cells (BECs) in asthma are poorly understood. 28931396 2017
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Moreover, administration of the IL-18 Adv to mice with established AHR greatly reduced AHR and IL-4 production and increased IFN-gamma production. 11342664 2001
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE Asthma is a chronic inflammatory airway disease associated with type 2 cytokines interleukin-4 (IL-4), IL-5, and IL-13, which promote airway eosinophilia, mucus overproduction, bronchial hyperresponsiveness (BHR), and immunogloubulin E (IgE) synthesis. 30995510 2019
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE IL13, rather than RAD50, IL4, or IL5, is more likely to be the asthma susceptibility gene. 27050946 2016
CUI: C0004096
Disease: Asthma
Asthma
0.600 Biomarker disease BEFREE NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma. 29182669 2017
CUI: C0004096
Disease: Asthma
Asthma
0.600 AlteredExpression disease BEFREE Additionally, it promoted the occurrence and development of asthma by influencing the expression levels of IL-7 and various relevant inflammatory factors (such as IL-4 and IL-8) and changing the equilibrium between Treg and Th17 cells. 30713661 2019